Review



customized mirna array panel  (Qiagen)


Bioz Verified Symbol Qiagen is a verified supplier
Bioz Manufacturer Symbol Qiagen manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Qiagen customized mirna array panel
    miR <t>expression</t> <t>profiles</t> in patients with VT ( DPYD 85T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with VT (n=4) and WT colorectal cancer (n=5) using miR array. (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of <t>miRNA.</t> Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; sn, small nuclear.
    Customized Mirna Array Panel, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 3479 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/customized+mirna+array+panel/miRNeasy+Serum%2FPlasma+Kit/pmc12464475-151-10-17
    Average 99 stars, based on 3479 article reviews
    customized mirna array panel - by Bioz Stars, 2026-11
    99/100 stars

    Images

    1) Product Images from "Association between miRNA expression profiles and polymorphisms of dihydropyrimidine dehydrogenase drug-metabolizing gene in patients with colorectal cancer receiving 5-fluorouracil"

    Article Title: Association between miRNA expression profiles and polymorphisms of dihydropyrimidine dehydrogenase drug-metabolizing gene in patients with colorectal cancer receiving 5-fluorouracil

    Journal: Biomedical Reports

    doi: 10.3892/br.2025.2053

    miR expression profiles in patients with VT ( DPYD 85T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with VT (n=4) and WT colorectal cancer (n=5) using miR array. (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; sn, small nuclear.
    Figure Legend Snippet: miR expression profiles in patients with VT ( DPYD 85T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with VT (n=4) and WT colorectal cancer (n=5) using miR array. (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; sn, small nuclear.

    Techniques Used: Expressing, Clinical Proteomics, Quantitative Proteomics, Variant Assay

    miRNA expression profiles in patients with VT ( DPYD 1896T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with (n=3) and WT colorectal cancer (n=3). (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; snRNA, small nuclear RNA.
    Figure Legend Snippet: miRNA expression profiles in patients with VT ( DPYD 1896T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with (n=3) and WT colorectal cancer (n=3). (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; snRNA, small nuclear RNA.

    Techniques Used: Expressing, Clinical Proteomics, Quantitative Proteomics, Variant Assay

    Related Articles

    Clinical Proteomics:

    Article Title: Plasma hsa-miRNA-145 Levels in Peruvian Women: In Silico Analysis and Inferences for Breast Cancer
    Article Snippet: .. RNA was extracted from plasma using the miRNeasy Serum/Plasma kit (Qiagen, Hilden, Germany), following the manufacturer’s protocol [18]. ..

    Article Title: Integrated Plasma snoRNA–Protein Network Analysis Identifies Circulating Molecular Signatures Associated with High-Risk Benign Breast Lesions and Early Breast Cancer
    Article Snippet: .. Total RNA was isolated from 200 μL of plasma using the miRNeasy Serum/Plasma Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s protocol. ..

    Article Title: Clinical Stage-Specific Alteration of hsa-miR-424-5p in Milk Small Extracellular Vesicles from Bovine Leukemia Virus Infection to Progression of Enzootic Bovine Leukosis.
    Article Snippet: .. RNA was extracted from the collected milk sEVs pellets using the miRNeasy Serum and Plasma Kit (217184; Qiagen). .. The concentration of the extracted RNA was determined using a QuantiFluor RNA System (E3310, Promega).

    Isolation:

    Article Title: Integrated Plasma snoRNA–Protein Network Analysis Identifies Circulating Molecular Signatures Associated with High-Risk Benign Breast Lesions and Early Breast Cancer
    Article Snippet: .. Total RNA was isolated from 200 μL of plasma using the miRNeasy Serum/Plasma Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s protocol. ..

    Article Title: Maternal Sedentary Behavior and Breast Milk Extracellular Vesicle MicroRNA Across Pregnancy: A Pilot Study.
    Article Snippet: .. Total RNA was isolated from 200 μL of isolated EVs using the Qiagen miRNeasy Serum/Plasma kit (Qiagen, Cat. No. 217184; Hilden, Germany) following the manufacturer’s instructions without alteration. ..

    Article Title: MicroRNA signatures of equine asthma phenotypes in serum and bronchoalveolar lavage fluid.
    Article Snippet: .. Total RNA was isolated from both serum and BALF samples using the miRNeasy serum/plasma kit (Qiagen) following the manufacturer’s protocol. ..

    Exosomes:

    Article Title: Eight weeks of increased daily walking are associated with changes in circulating exosomal miRNA profiles in healthy male adults: A pilot study
    Article Snippet: Exosomes were isolated from plasma samples (500 μL) using the miRCURY Exosome Kit (76603, Qiagen, Venlo, Netherlands), and the high‐purity exosomes were utilized for downstream analyses. .. Small RNAs of approximately 25 nucleotides were extracted from the collected exosomes using the miRNeasy Kit (217184, Qiagen, Venlo, Netherlands), and their concentration and quality were measured with the Agilent 2100 Bioanalyzer (Agilent Technologies, CA, USA). .. For sequencing, small RNA libraries were prepared using the Small RNA Library Prep Kit for Illumina (RS‐200‐0012, CA, USA), and miRNA sequencing was performed on the Illumina NovaSeq 6000 platform.

    Concentration Assay:

    Article Title: Eight weeks of increased daily walking are associated with changes in circulating exosomal miRNA profiles in healthy male adults: A pilot study
    Article Snippet: Exosomes were isolated from plasma samples (500 μL) using the miRCURY Exosome Kit (76603, Qiagen, Venlo, Netherlands), and the high‐purity exosomes were utilized for downstream analyses. .. Small RNAs of approximately 25 nucleotides were extracted from the collected exosomes using the miRNeasy Kit (217184, Qiagen, Venlo, Netherlands), and their concentration and quality were measured with the Agilent 2100 Bioanalyzer (Agilent Technologies, CA, USA). .. For sequencing, small RNA libraries were prepared using the Small RNA Library Prep Kit for Illumina (RS‐200‐0012, CA, USA), and miRNA sequencing was performed on the Illumina NovaSeq 6000 platform.



    Similar Products

    99
    Qiagen customized mirna array panel
    miR <t>expression</t> <t>profiles</t> in patients with VT ( DPYD 85T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with VT (n=4) and WT colorectal cancer (n=5) using miR array. (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of <t>miRNA.</t> Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; sn, small nuclear.
    Customized Mirna Array Panel, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/customized+mirna+array+panel/miRNeasy+Serum%2FPlasma+Kit/pmc12464475-151-10-17
    Average 99 stars, based on 1 article reviews
    customized mirna array panel - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    miR expression profiles in patients with VT ( DPYD 85T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with VT (n=4) and WT colorectal cancer (n=5) using miR array. (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; sn, small nuclear.

    Journal: Biomedical Reports

    Article Title: Association between miRNA expression profiles and polymorphisms of dihydropyrimidine dehydrogenase drug-metabolizing gene in patients with colorectal cancer receiving 5-fluorouracil

    doi: 10.3892/br.2025.2053

    Figure Lengend Snippet: miR expression profiles in patients with VT ( DPYD 85T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with VT (n=4) and WT colorectal cancer (n=5) using miR array. (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; sn, small nuclear.

    Article Snippet: The miRNA expression profiles were analyzed using RT-PCR with a customized miRNA array panel (cat. no. 217184; Qiagen GmbH) coated with specific primers for 43 miRNAs (sequences not provided) involved in the 5-FU metabolic pathway. miR target sequences are listed in .

    Techniques: Expressing, Clinical Proteomics, Quantitative Proteomics, Variant Assay

    miRNA expression profiles in patients with VT ( DPYD 1896T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with (n=3) and WT colorectal cancer (n=3). (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; snRNA, small nuclear RNA.

    Journal: Biomedical Reports

    Article Title: Association between miRNA expression profiles and polymorphisms of dihydropyrimidine dehydrogenase drug-metabolizing gene in patients with colorectal cancer receiving 5-fluorouracil

    doi: 10.3892/br.2025.2053

    Figure Lengend Snippet: miRNA expression profiles in patients with VT ( DPYD 1896T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with (n=3) and WT colorectal cancer (n=3). (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; snRNA, small nuclear RNA.

    Article Snippet: The miRNA expression profiles were analyzed using RT-PCR with a customized miRNA array panel (cat. no. 217184; Qiagen GmbH) coated with specific primers for 43 miRNAs (sequences not provided) involved in the 5-FU metabolic pathway. miR target sequences are listed in .

    Techniques: Expressing, Clinical Proteomics, Quantitative Proteomics, Variant Assay